MLchartDataset catalogue

URLC10 peptide/Montanide ISA51 vaccine

Term · Oncology and biomedicine · MLC-T-ONC-017419

A cancer vaccine containing URLC10 (up-regulated lung cancer 10) epitopes with potential immunostimulatory and antineoplastic activities. Upon administration, URL peptide vaccine may stimulate a cytotoxic T lymphocyte (CTL) response against URLC10-expressing tumor cells. Up-regulated in lung and esophageal cancers, the function of URLC10 is unknown.

Table 1. Record
IdentifierMLC-T-ONC-017419
FieldOncology and biomedicine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON 
{
  "id": "MLC-T-ONC-017419",
  "term": "URLC10 peptide/Montanide ISA51 vaccine",
  "field": "Oncology and biomedicine",
  "definition": "A cancer vaccine containing URLC10 (up-regulated lung cancer 10) epitopes with potential immunostimulatory and antineoplastic activities. Upon administration, URL peptide vaccine may stimulate a cytotoxic T lymphocyte (CTL) response against URLC10-expressing tumor cells. Up-regulated in lung and esophageal cancers, the function of URLC10 is unknown.",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/urlc10-peptide-montanide-isa51-vaccine/"
}

Record 17,002 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.